Abstract
Over the past two decades, many studies reported the benefits of higher 25-hydroxyvitamin D [25(OH)D] concentrations for nonskeletal effects. Researchers found significant benefits in reducing risk of acute respiratory tract infections, many types of cancer, type 2 diabetes mellitus, premature death, and adverse pregnancy and birth outcomes. In addition, 25(OH)D concentrations are low for various reasons in several categories of people, including the obese, those with dark skin living at higher latitudes, the elderly, and those who do not eat much eggs, fish, meat, or vitamin D fortified milk. Measuring 25(OH)D concentrations is one way to both increase the awareness of vitamin D’s importance in maintaining good health and to encourage vitamin D supplementation or increased solar ultraviolet-B exposure to sustain well-being throughout life by reducing disease incidence. Although 20 ng/ml seems adequate to reduce risk of skeletal problems and acute respiratory tract infections, concentrations above 30 ng/ml have been associated with reduced risk of cancer, type 2 diabetes mellitus, and adverse pregnancy and birth outcomes. Thus, judicious testing of 25(OH)D concentrations could reduce disease incidence and make treatment expenditures more cost-effective.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Pludowski P, Holick MF, Grant WB, Konstantynowicz J, Mascarenhas MR, Haq A, et al. Vitamin D supplementation guidelines. J steroid Biochem Mol Biol. 2018;175:125–35. https://doi.org/10.1016/j.jsbmb.2017.01.021.
McDonnell SL, Baggerly C, French CB, Baggerly LL, Garland CF, Gorham ED, et al. Serum 25-Hydroxyvitamin D Concentrations >/=40 ng/ml Are associated with >65% lower cancer risk: pooled analysis of randomized trial and prospective cohort study. PLoS ONE. 2016;11:e0152441. https://doi.org/10.1371/journal.pone.0152441.
McDonnell SL, Baggerly CA, French CB, Baggerly LL, Garland CF, Gorham ED, et al. Breast cancer risk markedly lower with serum 25-hydroxyvitamin D concentrations >/=60 vs <20 ng/ml (150 vs 50 nmol/L): pooled analysis of two randomized trials and a prospective cohort. PLoS ONE. 2018;13:e0199265. https://doi.org/10.1371/journal.pone.0199265.
Manson JE, Cook NR, Lee IM, Christen W, Bassuk SS, Mora S, et al. Vitamin D supplements and prevention of cancer and cardiovascular disease. N Engl J Med. 2019;380:33–44. https://doi.org/10.1056/NEJMoa1809944.
Pittas AG, Dawson-Hughes B, Sheehan P, Ware JH, Knowler WC, Aroda VR, et al. Vitamin D supplementation and prevention of type 2 diabetes. N Engl J Med. 2019;381:520–30. https://doi.org/10.1056/NEJMoa1900906.
Martineau AR, Jolliffe DA, Hooper RL, Greenberg L, Aloia JF, Bergman P, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. 2017;356:i6583. https://doi.org/10.1136/bmj.i6583.
Mirhosseini N, Vatanparast H, Kimball SM. The association between serum 25(OH)D status and blood pressure in participants of a community-based program taking vitamin D supplements. Nutrients. 2017;9:E1244. https://doi.org/10.3390/nu9111244.
McDonnell SL, Baggerly KA, Baggerly CA, Aliano JL, French CB, Baggerly LL, et al. Maternal 25(OH)D concentrations >/=40 ng/mL associated with 60% lower preterm birth risk among general obstetrical patients at an urban medical center. PLoS ONE. 2017;12:e0180483. https://doi.org/10.1371/journal.pone.0180483.
Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266–81. https://doi.org/10.1056/NEJMra070553.
Bilinski K, Boyages S. Evidence of overtesting for vitamin D in Australia: an analysis of 4.5 years of Medicare Benefits Schedule (MBS) data. BMJ Open 2013;3. https://doi.org/10.1136/bmjopen-2013-002955.
Basatemur E, Hunter R, Horsfall L, Sutcliffe A, Rait G. Costs of vitamin D testing and prescribing among children in primary care. Eur J Pediatr. 2017;176:1405–9. https://doi.org/10.1007/s00431-017-2986-9.
Woodford HJ, Barrett S, Pattman S. Vitamin D: too much testing and treating? Clin Med (Lond). 2018;18:196–200. https://doi.org/10.7861/clinmedicine.18-3-196.
Alazzeh A, Cooper MM, Bailey B, Youssef DA, Manning T, Peiris AN. Vitamin D status and monitoring in female veterans. Women Health. 2015;55:367–77. https://doi.org/10.1080/03630242.2015.1022685.
Rockwell M, Kraak V, Hulver M, Epling J. Clinical management of low vitamin D: a scoping review of physicians’ practices. Nutrients. 2018;10:E493. https://doi.org/10.3390/nu10040493.
Crowe FL, Jolly K, MacArthur C, Manaseki-Holland S, Gittoes N, Hewison M, et al. Trends in the incidence of testing for vitamin D deficiency in primary care in the UK: a retrospective analysis of The Health Improvement Network (THIN), 2005–2015. BMJ Open. 2019;9:e028355. https://doi.org/10.1136/bmjopen-2018–028355.
Figueiredo ACC, Cocate PG, Adegboye ARA, Franco-Sena AB, Farias DR, de Castro MBT, et al. Changes in plasma concentrations of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D during pregnancy: a Brazilian cohort. Eur J Nutr. 2018;57:1059–72. https://doi.org/10.1007/s00394-017-1389-z.
Yuan Y, Tai W, Xu P, Fu Z, Wang X, Long W, et al. Association of maternal serum 25-hydroxyvitamin D concentrations with risk of preeclampsia: a nested case-control study and meta-analysis. J Matern Fetal Neonatal Med. 2019:1–10. https://doi.org/10.1080/14767058.2019.1640675.
Fogacci S, Fogacci F, Banach M, Michos ED, Hernandez AV, Lip GYH, et al. Vitamin D supplementation and incident preeclampsia: a systematic review and meta-analysis of randomized clinical trials. Clin Nutr. 2019. https://doi.org/10.1016/j.clnu.2019.08.015.
Zhang Y, Gong Y, Xue H, Xiong J, Cheng G. Vitamin D and gestational diabetes mellitus: a systematic review based on data free of Hawthorne effect. BJOG. 2018;125:784–93. https://doi.org/10.1111/1471-0528.15060.
Garcia-Serna AM, Morales E. Neurodevelopmental effects of prenatal vitamin D in humans: systematic review and meta-analysis. Mol Psychiatry. 2019. https://doi.org/10.1038/s41380-019-0357-9.
Rostami M, Tehrani FR, Simbar M, Bidhendi Yarandi R, Minooee S, Hollis BW, et al. Effectiveness of prenatal vitamin D deficiency screening and treatment program: a stratified randomized field trial. J Clin Endocrinol Metab. 2018;103:2936–48. https://doi.org/10.1210/jc.2018-00109.
Wagner CL, Hollis BW. The implications of vitamin D status during pregnancy on mother and her developing child. Front Endocrinol. 2018;9:500. https://doi.org/10.3389/fendo.2018.00500.
Vasarhelyi B, Satori A, Olajos F, Szabo A, Beko G. [Low vitamin D levels among patients at Semmelweis University: retrospective analysis during a one-year period]. Orv Hetil. 2011;152:1272–7. https://doi.org/10.1556/OH.2011.29187.
MacLaughlin J, Holick MF. Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest. 1985;76:1536–8. https://doi.org/10.1172/JCI112134.
Xu JQ. Mortality Patterns Between Five States With Highest Death Rates and Five States With Lowest Death Rates: United States, 2017. Hyattsville: National Center for Health Statistics; 2019.
Garland CF, Kim JJ, Mohr SB, Gorham ED, Grant WB, Giovannucci EL, et al. Meta-analysis of all-cause mortality according to serum 25-hydroxyvitamin D. Am J public health. 2014;104:e43–50. https://doi.org/10.2105/AJPH.2014.302034.
Grant WB. An estimate of the global reduction in mortality rates through doubling vitamin D levels. Eur J Clin Nutr. 2011;65:1016–26. https://doi.org/10.1038/ejcn.2011.68. e-pub ahead of print 2011/07/07.
Ginde AA, Liu MC, Camargo CA Jr. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med. 2009;169:626–32. https://doi.org/10.1001/archinternmed.2008.604.
Aloia JF. African Americans, 25-hydroxyvitamin D, and osteoporosis: a paradox. Am J Clin Nutr. 2008;88:545S–50S. https://doi.org/10.1093/ajcn/88.2.545S.
Grant WB, Peiris AN. Differences in vitamin D status may account for unexplained disparities in cancer survival rates between African and white Americans. Derm-Endocrinol. 2012;4:85–94. https://doi.org/10.4161/derm.19667.
Jablonski NG, Chaplin G. The evolution of human skin coloration. J Hum Evol. 2000;39:57–106. https://doi.org/10.1006/jhev.2000.0403.
Crowe FL, Steur M, Allen NE, Appleby PN, Travis RC, Key TJ. Plasma concentrations of 25-hydroxyvitamin D in meat eaters, fish eaters, vegetarians and vegans: results from the EPIC-Oxford study. Public health Nutr. 2011;14:340–6. https://doi.org/10.1017/S1368980010002454.
Grant WB, Fakhoury HMA, Karras SN, Al Anouti F, Bhattoa HP. Variations in 25-Hydroxyvitamin D in Countries from the Middle East and Europe: the roles of UVB Exposure and diet. Nutrients. 2019;11:E2065. https://doi.org/10.3390/nu11092065.
Han TS, Lean ME. A clinical perspective of obesity, metabolic syndrome and cardiovascular disease. JRSM cardiovascular Dis. 2016;5:2048004016633371. https://doi.org/10.1177/2048004016633371.
Moukayed M, Grant WB. Linking the metabolic syndrome and obesity with vitamin D status: risks and opportunities for improving cardiometabolic health and well-being. Diabetes Metab Syndr Obes. 2019;12:1437–47. https://doi.org/10.2147/DMSO.S176933.
Jungert A, Roth HJ, Neuhauser-Berthold M. Serum 25-hydroxyvitamin D3 and body composition in an elderly cohort from Germany: a cross-sectional study. Nutr Metab. 2012;9:42. https://doi.org/10.1186/1743-7075-9-42.
Lee SH, Kim SM, Park HS, Choi KM, Cho GJ, Ko BJ, et al. Serum 25-hydroxyvitamin D levels, obesity and the metabolic syndrome among Korean children. Nutr, Metab, cardiovascular Dis: NMCD. 2013;23:785–91. https://doi.org/10.1016/j.numecd.2012.04.013.
Heaney RP, Horst RL, Cullen DM, Armas LA. Vitamin D3 distribution and status in the body. J Am Coll Nutr. 2009;28:252–6.
Zittermann A, Ernst JB, Gummert JF, Borgermann J. Vitamin D supplementation, body weight and human serum 25-hydroxyvitamin D response: a systematic review. Eur J Nutr. 2014;53:367–74. https://doi.org/10.1007/s00394-013-0634-3.
Gallagher JC, Sai A, Templin T II, Smith L. Dose response to vitamin D supplementation in postmenopausal women: a randomized trial. Ann Intern Med. 2012;156:425–37. https://doi.org/10.7326/0003-4819-156-6-201203200-00005.
Gallagher JC, Yalamanchili V, Smith LM. The effect of vitamin D supplementation on serum 25(OH)D in thin and obese women. J steroid Biochem Mol Biol. 2013;136:195–200. https://doi.org/10.1016/j.jsbmb.2012.12.003.
Imga NN, Karci AC, Oztas D, Berker D, Guler S. Effects of vitamin D supplementation on insulin resistance and dyslipidemia in overweight and obese premenopausal women. Arch Med Sci: AMS. 2019;15:598–606. https://doi.org/10.5114/aoms.2018.75864.
Hussain Gilani SY, Bibi S, Siddiqui A, Ali Shah SR, Akram F, Rehman MU. Obesity and diabetes as determinants of vitamin D deficiency. J Ayub Med Coll Abbottabad. 2019;31:432–35.
Tabrizi JS, Sadeghi-Bazargani H, Farahbakhsh M, Nikniaz L, Nikniaz Z. Prevalence and associated factors of overweight or obesity and abdominal obesity in iranian population: A Population-based Study of Northwestern Iran. Iran J Public Health. 2018;47:1583–92.
Zhang FF, Al Hooti S, Al Zenki S, Alomirah H, Jamil KM, Rao A, et al. Vitamin D deficiency is associated with high prevalence of diabetes in Kuwaiti adults: results from a national survey. BMC Public Health. 2016;16:100. https://doi.org/10.1186/s12889-016-2758-x.
Al Zarooni AAR, Al Marzouqi FI, Al Darmaki SH, Prinsloo EAM, Nagelkerke N. Prevalence of vitamin D deficiency and associated comorbidities among Abu Dhabi Emirates population. BMC Res Notes. 2019;12:503. https://doi.org/10.1186/s13104-019-4536-1.
WHO. World Health Statistics 2016: Annex B: Tables of health statistics by country, WHO region and globally. Report no: 978 92 4 156526 4. Geneva: World Health Organization; 2016.
Mozaffarian D. Dietary and policy priorities for cardiovascular disease, diabetes, and obesity: a comprehensive review. Circulation. 2016;133:187–225. https://doi.org/10.1161/CIRCULATIONAHA.115.018585.
Bazzano LA, He J, Muntner P, Vupputuri S, Whelton PK. Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States. Ann Intern Med. 2003;138:891–7. https://doi.org/10.7326/0003-4819-138-11-200306030-00010.
Wang L, Song Y, Manson JE, Pilz S, Marz W, Michaelsson K, et al. Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes. 2012;5:819–29. https://doi.org/10.1161/CIRCOUTCOMES.112.967604.
Shi H, Chen H, Zhang Y, Li J, Fu K, Xue W, et al. 25-Hydroxyvitamin D level, vitamin D intake, and risk of stroke: a dose-response meta-analysis. Clin Nutr. 2019. https://doi.org/10.1016/j.clnu.2019.08.029.
Zhou R, Wang M, Huang H, Li W, Hu Y, Wu T. Lower Vitamin D Status Is Associated With An Increased Risk Of Ischemic Stroke: A Systematic Review And Meta-analysis. Nutrients. 2018;10:E277. https://doi.org/10.3390/nu10030277.
Barbarawi M, Kheiri B, Zayed Y, Barbarawi O, Dhillon H, Swaid B, et al. Vitamin D supplementation and cardiovascular disease risks in more than 83000 individuals in 21 randomized clinical trials: a meta-analysis. JAMA Cardiol. 2019. https://doi.org/10.1001/jamacardio.2019.1870.
Grant WB, Boucher BJ, Bhattoa HP, Lahore H. Why vitamin D clinical trials should be based on 25-hydroxyvitamin D concentrations. J steroid Biochem Mol Biol. 2018;177:266–9. https://doi.org/10.1016/j.jsbmb.2017.08.009.
Grant WB, Bhattoa HP, Boucher BJ. Seasonal variations of U.S. mortality rates: Roles of solar ultraviolet-B doses, vitamin D, gene exp ression, and infections. J steroid Biochem Mol Biol. 2017;173:5–12. https://doi.org/10.1016/j.jsbmb.2017.01.003.
Kroll MH, Bi C, Garber CC, Kaufman HW, Liu D, Caston-Balderrama A, et al. Temporal relationship between vitamin D status and parathyroid hormone in the United States. PloS ONE. 2015;10:e0118108. https://doi.org/10.1371/journal.pone.0118108.
Moukayed M, Grant WB. Molecular link between vitamin D and cancer prevention. Nutrients. 2013;5:3993–4021. https://doi.org/10.3390/nu5103993.
McCullough ML, Zoltick ES, Weinstein SJ, Fedirko V, Wang M, Cook NR, et al. Circulating vitamin D and colorectal cancer risk: an International Pooling Project of 17 Cohorts. J Natl Cancer Inst. 2019;111:158–69. https://doi.org/10.1093/jnci/djy087.
Maalmi H, Walter V, Jansen L, Boakye D, Schottker B, Hoffmeister M, et al. Association between blood 25-hydroxyvitamin D levels and survival in colorectal cancer patients: an updated systematic review and meta-analysis. Nutrients. 2018;10:E896. https://doi.org/10.3390/nu10070896.
Madden JM, Murphy L, Zgaga L, Bennett K. De novo vitamin D supplement use post-diagnosis is associated with breast cancer survival. Breast Cancer Res Treat. 2018;172:179–90. https://doi.org/10.1007/s10549-018-4896-6.
Grant WB, Boucher BJ. Why secondary analyses in vitamin d clinical trials are important and how to improve vitamin D clinical trial outcome analyses—a comment on “extra-skeletal effects of vitamin D, nutrients 2019, 11, 1460”. Nutrients. 2019;11:2182. https://doi.org/10.3390/nu11092182.
Zhu M, Wang T, Wang C, Ji Y. The association between vitamin D and COPD risk, severity, and exacerbation: an updated systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2016;11:2597–607. https://doi.org/10.2147/COPD.S101382.
Cannell JJ, Vieth R, Umhau JC, Holick MF, Grant WB, Madronich S, et al. Epidemic influenza and vitamin D. Epidemiol Infect. 2006;134:1129–40.
Urashima M, Segawa T, Okazaki M, Kurihara M, Wada Y, Ida H. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr. 2010;91:1255–60. https://doi.org/10.3945/ajcn.2009.29094.
Amrein K, Papinutti A, Mathew E, Vila G, Parekh D. Vitamin D and critical illness: what endocrinology can learn from intensive care and vice versa. Endocr Connect. 2018;7:R304–15. https://doi.org/10.1530/EC-18-0184.
de Haan K, Groeneveld AB, de Geus HR, Egal M, Struijs A. Vitamin D deficiency as a risk factor for infection, sepsis and mortality in the critically ill: systematic review and meta-analysis. Crit Care. 2014;18:660. https://doi.org/10.1186/s13054-014-0660-4.
Moromizato T, Litonjua AA, Braun AB, Gibbons FK, Giovannucci E, Christopher KB. Association of low serum 25-hydroxyvitamin D levels and sepsis in the critically ill. Crit Care Med. 2014;42:97–107. https://doi.org/10.1097/CCM.0b013e31829eb7af.
Quraishi SA, Bittner EA, Blum L, McCarthy CM, Bhan I, Camargo CA Jr. Prospective study of vitamin D status at initiation of care in critically ill surgical patients and risk of 90-day mortality. Crit Care Med. 2014;42:1365–71. https://doi.org/10.1097/CCM.0000000000000210.
Arnson Y, Gringauz I, Itzhaky D, Amital H. Vitamin D deficiency is associated with poor outcomes and increased mortality in severely ill patients. QJM. 2012;105:633–9. https://doi.org/10.1093/qjmed/hcs014.
Braun AB, Gibbons FK, Litonjua AA, Giovannucci E, Christopher KB. Low serum 25-hydroxyvitamin D at critical care initiation is associated with increased mortality. Crit Care Med. 2012;40:63–72. https://doi.org/10.1097/CCM.0b013e31822d74f3.
Matthews LR, Ahmed Y, Wilson KL, Griggs DD, Danner OK. Worsening severity of vitamin D deficiency is associated with increased length of stay, surgical intensive care unit cost, and mortality rate in surgical intensive care unit patients. Am J Surg. 2012;204:37–43. https://doi.org/10.1016/j.amjsurg.2011.07.021.
Langlois PL, Szwec C, D’Aragon F, Heyland DK, Manzanares W. Vitamin D supplementation in the critically ill: a systematic review and meta-analysis. Clin Nutr. 2018;37:1238–46. https://doi.org/10.1016/j.clnu.2017.05.006.
Amrein K, Schnedl C, Holl A, Riedl R, Christopher KB, Pachler C, et al. Effect of high-dose vitamin D3 on hospital length of stay in critically ill patients with vitamin D deficiency: the VITdAL-ICU randomized clinical trial. Jama. 2014;312:1520–30. https://doi.org/10.1001/jama.2014.13204.
Quraishi SA, De Pascale G, Needleman JS, Nakazawa H, Kaneki M, Bajwa EK, et al. Effect of cholecalciferol supplementation on vitamin D status and cathelicidin levels in sepsis: a randomized, placebo-controlled Trial. Crit Care Med. 2015;43:1928–37. https://doi.org/10.1097/CCM.0000000000001148.
Han JE, Jones JL, Tangpricha V, Brown MA, Brown LAS, Hao L, et al. high dose vitamin D administration in ventilated intensive care unit patients: a pilot double blind randomized controlled trial. J Clin Transl Endocrinol. 2016;4:59–65. https://doi.org/10.1016/j.jcte.2016.04.004.
Dursun E, Gezen-Ak D. Vitamin D basis of Alzheimer’s disease: from genetics to biomarkers. Hormones. 2019;18:7–15. https://doi.org/10.1007/s42000-018-0086-5.
Nelis SM, Wu YT, Matthews FE, Martyr A, Quinn C, Rippon I, et al. The impact of co-morbidity on the quality of life of people with dementia: findings from the IDEAL study. Age Ageing. 2019;48:361–7. https://doi.org/10.1093/ageing/afy155.
Bailey BA, Manning T, Peiris AN. Vitamin D testing patterns among six veterans medical centers in the Southeastern United States: links with medical costs. Mil Med. 2012;177:70–76. https://doi.org/10.7205/milmed-d-11-00204.
Der T, Bailey BA, Youssef D, Manning T, Grant WB, Peiris AN. Vitamin D and prostate cancer survival in veterans. Mil Med. 2014;179:81–84. https://doi.org/10.7205/MILMED-D-12-00540.
Hannemann A, Wallaschofski H, Nauck M, Marschall P, Flessa S, Grabe HJ, et al. Vitamin D and health care costs: results from two independent population-based cohort studies. Clin Nutr. 2018;37:2149–55. https://doi.org/10.1016/j.clnu.2017.10.014.
Annweiler C, Kabeshova A, Callens A, Paty ML, Duval GT, Holick MF. Self-administered vitamin D status predictor: older adults are able to use a self-questionnaire for evaluating their vitamin D status. PloS ONE. 2017;12:e0186578. https://doi.org/10.1371/journal.pone.0186578.
Chevallereau G, Legeay M, Duval GT, Karras SN, Fantino B, Annweiler C. Profiling older community-dwellers with hypovitaminosis D: a classification tree analysis. Int J Vitam Nutr Res. 2019: 1–5. https://doi.org/10.1024/0300-9831/a000591.
Engelsen O. The relationship between ultraviolet radiation exposure and vitamin D status. Nutrients. 2010;2:482–95. https://doi.org/10.3390/nu2050482.
Ferrari D, Lombardi G, Strollo M, Pontillo M, Motta A, Locatelli M. Association between solar ultraviolet doses and vitamin D clinical routine data in European mid-latitude population between 2006 and 2018. Photochem Photobiol Sci. 2019. https://doi.org/10.1039/c9pp00372j.
Pilz S, Marz W, Cashman KD, Kiely ME, Whiting SJ, Holick MF, et al. Rationale and plan for vitamin D food fortification: a review and guidance paper. Front Endocrinol. 2018;9:373. https://doi.org/10.3389/fendo.2018.00373.
Jaaskelainen T, Itkonen ST, Lundqvist A, Erkkola M, Koskela T, Lakkala K, et al. The positive impact of general vitamin D food fortification policy on vitamin D status in a representative adult Finnish population: evidence from an 11-y follow-up based on standardized 25-hydroxyvitamin D data. Am J Clin Nutr. 2017;105:1512–20. https://doi.org/10.3945/ajcn.116.151415.
Roth DE, Abrams SA, Aloia J, Bergeron G, Bourassa MW, Brown KH, et al. Global prevalence and disease burden of vitamin D deficiency: a roadmap for action in low- and middle-income countries. Ann N. Y Acad Sci. 2018;1430:44–79. https://doi.org/10.1111/nyas.13968.
Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr. 2003;77:204–10.
Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:1911–30. https://doi.org/10.1210/jc.2011-0385.
Author information
Authors and Affiliations
Contributions
WBG was responsible for designing the review, conducting much of the literature search, interpretation of findings, drafting most of the paper, and updating reference lists. FAA was responsible for searching the literature, drafting a portion of the paper, and interpreting the results. MM was responsible for searching the literature, connecting and interpreting findings and drafting portions of the paper.
Corresponding author
Ethics declarations
Conflict of interest
WBG receives funding from Bio-Tech Pharmacal, Inc. (Fayetteville, AR, USA). The other authors have no conflicts of interest to declare.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Grant, W.B., Al Anouti, F. & Moukayed, M. Targeted 25-hydroxyvitamin D concentration measurements and vitamin D3 supplementation can have important patient and public health benefits. Eur J Clin Nutr 74, 366–376 (2020). https://doi.org/10.1038/s41430-020-0564-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41430-020-0564-0
This article is cited by
-
Hypothesized pathways for the association of vitamin D status and insulin sensitivity with resting energy expenditure: a cross sectional mediation analysis in Australian adults of European ancestry
European Journal of Clinical Nutrition (2022)
-
25-Hydroxyvitamin D reference percentiles and the role of their determinants among European children and adolescents
European Journal of Clinical Nutrition (2022)
-
Vitamin D deficiency and tumor aggressiveness in gastroenteropancreatic neuroendocrine tumors
Endocrine (2022)
-
The evident and the hidden factors of vitamin D status in older people during COVID-19 pandemic
Nutrire (2021)
-
Non-classical presentation of vitamin D deficiency: a case report
Journal of Medical Case Reports (2020)